GUANGZHOU PHAR<00874> - Results Announcement (Summary)
Guangzhou Pharmaceutical Company Limited announced on 4/4/2002:
(stock code: 874)
Year end date: 31/12/2001
Currency: RMB
Auditors' Report: Neither
Review of Interim Report by: N/A
(Audited)
(Audited) Last
Current Corresponding
Period Period
from 1/1/2001 from 1/1/2000
to 31/12/2001 to 31/12/2000
('000) ('000)
Turnover : 5,334,029 4,222,857
Profit/(Loss) from Operations : 245,110 247,877
Finance cost : (29,726) (39,207)
Share of Profit/(Loss) of Associates : 509 (3,257)
Share of Profit/(Loss) of
Jointly Controlled Entities : (9,906) (841)
Profit/(Loss) after Tax & MI : 95,868 135,250
% Change over Last Period : -29%
EPS/(LPS)-Basic : RMB0.119 RMB0.185
-Diluted : N/A N/A
Extraordinary (ETD) Gain/(Loss) : - -
Profit/(Loss) after ETD Items : 95,868 135,250
Final Dividend per H Share : RMB0.06 RMB0.03
(Specify if with other options) : - -
B/C Dates for Final Dividend : 8/5/2002 to 7/6/2002 bdi.
Payable Date : 21/6/2002
B/C Dates for Annual General Meeting : 8/5/2002 to 7/6/2002 bdi.
Other Distribution for Current Period : N/A
B/C Dates for Other Distribution : N/A
Remark:
In 2001, there was an impairment charge on fixed assets and construction
in progress amounted to Rmb50,119,000, arising from continuing operations.
Impairment charge included:
Rmb'000
Fixed assets 38,191
Construction in progress 11,928
--------
50,119
========
Impairment charge mainly arose as a result of technology upgrade and
modernisation of production facilities.
|
